Summary
EU medicines regulators’ plan to leverage data & AI in regulatory science (governance, LLM use, evidence generation, data interoperability) through 2028.
Healthcare Implications
Shapes how AI tools/data are used in medicines evaluation and pharmacovigilance – affecting sponsors, MAHs, and clinical research that use AI.